Tri Chemical Laboratories Inc.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 4 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/03/13 | ¥43.77 | ¥45.96 | +5.0% |
| 2025/03/14 | ¥54.57 | ¥53.40 | -2.1% |
| 2024/11/28 | ¥43.10 | ¥36.78 | -14.7% |
| 2024/08/29 | ¥26.30 | ¥37.51 | +42.6% |
Shareholder Composition
Updated 2026/10/01Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥35 | 0.0% |
| 2025 | ¥35 | +16.7% |
| 2024 | ¥30 | 0.0% |
| 2023 | ¥30 | +50.0% |
| 2022 | ¥20 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥13,803M | ¥11,246M | ¥18,906M | ¥23,883M |
| Gross Profit | ¥5,579M | ¥4,086M | ¥8,012M | ¥9,019M |
| Operating Income | ¥3,505M | ¥1,948M | ¥5,256M | ¥5,902M |
| Pretax Income | ¥6,215M | ¥3,300M | ¥6,607M | ¥7,125M |
| Net Income | ¥4,832M | ¥2,471M | ¥4,962M | ¥5,515M |
| EPS | ¥148.70 | ¥76.03 | ¥152.69 | ¥169.72 |
| Operating Margin | 25.39% | 17.32% | 27.80% | 24.71% |
| Balance Sheet | ||||
| Total Assets | ¥32,116M | ¥31,865M | ¥36,945M | ¥47,275M |
| Total Equity | ¥25,876M | ¥27,570M | ¥31,588M | ¥36,150M |
| Total Liabilities | ¥6,240M | ¥4,295M | ¥5,357M | ¥11,125M |
| Cash | ¥11,138M | ¥10,497M | ¥9,439M | ¥7,280M |
| Interest-bearing Debt | ¥3,245M | ¥2,400M | ¥1,778M | ¥4,126M |
| Equity Ratio | 80.57% | 86.52% | 85.50% | 76.47% |
| D/E Ratio | 0.13 | 0.09 | 0.06 | 0.11 |
| Cash Flow | ||||
| Operating CF | ¥6,392M | ¥2,972M | ¥3,675M | ¥3,795M |
| Investing CF | -¥1,558M | -¥1,782M | -¥3,116M | -¥7,054M |
| Financing CF | -¥1,704M | -¥1,859M | -¥1,620M | ¥1,088M |
| Free CF | ¥4,836M | ¥1,191M | ¥591M | -¥2,540M |
| Efficiency | ||||
| ROE | 18.68% | 8.96% | 15.71% | 15.26% |
| ROA | 15.05% | 7.75% | 13.43% | 11.67% |
Latest IR Information
-
Notice on the differences between the second quarter ( Interim ) results and the earnings forecasts and the full-year earnings forecast revision
For the second quarter of the fiscal year ending January 2027, actual results exceeded the previous forecast and the full-year outlook was revised upward. Revenue was 14,705 million yen, operating profit was 3,838 million yen, ordinary profit was 4,526 million...
Read more -
Q2 FY2027 Financial Results Summary (Interim) [Japanese GAAP] (Consolidated)
The second quarter ( interim) results for FY2027 show net sales of 14,705 million yen (up 18.8% YoY), operating income of 3,838 million yen (up 20.8%), ordinary income of 4,526 million yen (up 19.1%), and net income attributable to owners...
Read more -
Q1 FY2027 Financial Results Summary (Consolidated)
Trichemical Laboratory achieved net sales of 7,488,666 thousand yen (up 14.0% YoY) and net profit of 1,855,377 thousand yen (up 53.6% YoY) in the first quarter of FY2027, demonstrating solid business expansion.
Read more -
Financial Summary for the Fiscal Year Ending January 2026 [Japanese Standards] (Consolidated)
For the fiscal year ending January 2026, consolidated net sales were ¥23,883 million (26.3% YoY increase), operating income was ¥5,902 million (12.3% YoY increase), and net income attributable to owners of parent was ¥5,515 million (11.1% YoY increase).
Read more -
Notice Regarding the Formulation of the Medium-Term Management Plan
Formulated a three-year medium-term management plan starting in the fiscal year ending January 2027. Targets sales of 27,000 million yen and operating income of 6,000 million yen, planning to reach sales of 31,700 million yen and operating income of 8,650...
Read more -
Notice Regarding the Appointment of Candidates for Directors and Audit & Supervisory Board Members
Candidates for directors and audit & supervisory board members to be proposed at the 48th Annual General Meeting of Shareholders scheduled for April 27, 2026, have been determined. The new candidate for Audit & Supervisory Board Member is Mr. Satoru...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥3,998
Rating Score: 1.75 (Based on 4 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Tri Chemical Laboratories Inc. develops, manufactures, and sells high-purity chemicals for semiconductor manufacturing in Japan, Taiwan, China, South Korea, and internationally. The company offers Si semiconductors, coating, optical fiber, compound semiconductor, and reagents. It also provides analyses services, such as purity measurement, impurity measurement, and thermal stability tests, film-forming tests, stainless steel container with valve and overseas specifications, metal seamless container for high pressure gas, sealed glass ampoule, polyethylene container, glass screw cap bottle, glass vials bottle, and pipe cleaning. Tri Chemical Laboratories Inc. was incorporated in 1978 and is headquartered in Uenohara, Japan.
